Skip to main content
. Author manuscript; available in PMC: 2012 Mar 8.
Published in final edited form as: Circulation. 2011 Mar 8;123(9):1021–1037. doi: 10.1161/CIRCULATIONAHA.109.914838

Figure 4. Utility of Genetic Testing.

Figure 4

Shown is the current diagnostic, prognostic, and therapeutic utility of genetic testing for hypertrophic cardiomyopathy (HCM), long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS). The + symbol indicates the test has utility, the − symbol indicates no current measurable utility, and +/− indicates the test may have some utility.